Pulmonary infection due to Mycobacterium xenopi - In vitro sensitivity to classical antituberculotic drugs and clinical development

被引：11

作者：

Baugnee, PE ^{[1
]}

Pouthier, F ^{[1
]}

Delaunois, L ^{[1
]}

机构：

[1] CLIN UNIV UCL MONT GODINNE,SERV PNEUMOL,B-5530 YVOIR,BELGIUM

来源：

ACTA CLINICA BELGICA | 1996年 / 51卷 / 01期

关键词：

D O I：

10.1080/17843286.1996.11718481

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Out of 11 patients suffering from Mycobacterium xenopi lung disease, 9 were treated with an empiric antituberculous triple chemotherapy until specific identification and antibiogram were available. Despite the important ''in vitro'' resistance to drugs, most of the patients improved; in the other patients, the impairment was always due to the underlying pathology. We conclude that the ''in vivo'' response of M. xenopi infections to antituberculous drugs is little influenced by the ''in vitro'' sensitivity.

引用

页码：19 / 27

页数：9

共 57 条

[1] PULMONARY-LESIONS DUE TO OPPORTUNIST MYCOBACTERIA - (REVIEW INCLUDES 30 CASES OF MYCOBACTERIA-KANSASII INFECTIONS) [J].

ANDERSON, DH ;

GRECH, P ;

TOWNSHEND, RH ;

JEPHCOTT, AE .

CLINICAL RADIOLOGY, 1975, 26 (04) :461-469

[2] MYCOBACTERIUM-XENOPI INFECTIONS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].

AUSINA, V ;

BARRIO, J ;

LUQUIN, M ;

SAMBEAT, MA ;

GURGUI, M ;

VERGER, G ;

PRATS, G .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (11) :927-928

[3] PULMONARY INFECTION WITH MYCOBACTERIUM-XENOPI - REVIEW OF TREATMENT AND RESPONSE [J].

BANKS, J ;

HUNTER, AM ;

CAMPBELL, IA ;

JENKINS, PA ;

SMITH, AP .

THORAX, 1984, 39 (05) :376-382

[4]

BECK J., 1963, Tubercle, V44, P378, DOI 10.1016/S0041-3879(63)80109-9

[5]

BELLAMY J, 1987, REV MAL RESPIR, V4, P261

[6]

BENOIT JP, 1982, REV FR MAL RESPIR, V10, P453

[7]

BOGAERTS Y, 1982, EUR J RESPIR DIS, V63, P298

[8]

BOISVERT H, 1965, ANN I PASTEUR PARIS, V109, P447

[9]

BOISVERT H, 1971, B SOC MED PASSY, V37, P17

[10]

Bretey J, 1969, Rev Tuberc Pneumol (Paris), V33, P337

← 1 2 3 4 5 6 →